Submitted by Anonymous (not verified) on 29 April 2025 - 13:48
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised